Deep vein thrombosis on the fourth day of risperidone therapy.

Kavitha Konnakkaparambil Ramakrishnan, Mithila George

BMJ case reports 2021 Mar 05

filter terms:

Deep vein thrombosis has been recognised as a complication of antipsychotic treatment and is reported to be more common with atypical antipsychotics. Risperidone is a second-generation atypical antipsychotic and there have been case reports of risperidone-associated deep vein thrombosis, most of them reporting the complication from 2 weeks to a few months of initiation of therapy. Here, we are reporting a case of deep vein thrombosis in a male patient in his early forties with paranoid schizophrenia, which presented on the fourth day of starting risperidone therapy. This case is being reported to highlight the fact that deep vein thrombosis can occur as early as fourth day of initiation of risperidone therapy, that too at a low dose (2 mg/day). The case also emphasises the importance of monitoring these patients for this rare but potentially serious adverse effect from the first day itself after initiation of a new antipsychotic. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Citation

Kavitha Konnakkaparambil Ramakrishnan, Mithila George. Deep vein thrombosis on the fourth day of risperidone therapy. BMJ case reports. 2021 Mar 05;14(3)